{"DataElement":{"publicId":"2529202","version":"1","preferredName":"Loss Gene Expression Immunohistochemistry Staining Method Finding Loss Outcome LossResult","preferredDefinition":"A gradual decline in amount or activity.:Typically involves transcription of genetically encoded information into an intermediary message (messenger RNA) and subsequent translation into a functional protein.:Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.:Objective evidence of disease perceptible to the examining physician (sign) and subjective evidence of disease perceived by the patient (symptom)._A gradual decline in amount or activity.:A phenomenon that follows and is caused by some previous phenomenon._indicates the 3 level result, it is only assessable if benign tissue present","longName":"2528907v1.0:2529046v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2528907","version":"1","preferredName":"Loss Gene Expression Immunohistochemistry Staining Method Finding Loss Outcome","preferredDefinition":"A gradual decline in amount or activity.:Typically involves transcription of genetically encoded information into an intermediary message (messenger RNA) and subsequent translation into a functional protein.:Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.:Objective evidence of disease perceptible to the examining physician (sign) and subjective evidence of disease perceived by the patient (symptom)._A gradual decline in amount or activity.:A phenomenon that follows and is caused by some previous phenomenon.","longName":"2528742v1.0:2528660v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2528742","version":"1","preferredName":"Loss Gene Expression Immunohistochemistry Staining Method Finding","preferredDefinition":"A gradual decline in amount or activity.:Typically involves transcription of genetically encoded information into an intermediary message (messenger RNA) and subsequent translation into a functional protein.:Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.:Objective evidence of disease perceptible to the examining physician (sign) and subjective evidence of disease perceived by the patient (symptom).","longName":"C25559:C16608:C23020:C3367","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Loss","conceptCode":"C25559","definition":"A gradual decline in amount or activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Gene Expression","conceptCode":"C16608","definition":"Typically involves transcription of genetically encoded information into an intermediary message (messenger RNA) and subsequent translation into a functional protein.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Immunohistochemistry Staining Method","conceptCode":"C23020","definition":"Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Finding","conceptCode":"C3367","definition":"Clinical, laboratory or molecular evidence, or absence of evidence of disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"20415841-395F-0263-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-20","endDate":null,"createdBy":"UMLLOADER_CGOM","dateCreated":"2006-10-20","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2528660","version":"1","preferredName":"Loss Outcome","preferredDefinition":"A gradual decline in amount or activity.:A phenomenon that follows and is caused by some previous phenomenon.","longName":"C25559:C20200","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Loss","conceptCode":"C25559","definition":"A gradual decline in amount or activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"20414889-27FA-6DD5-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-20","endDate":null,"createdBy":"UMLLOADER_CGOM","dateCreated":"2006-10-20","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2222502","version":"1","preferredName":"UML DEFAULT CD","preferredDefinition":"Default Conceptual Domain for UML Loader","longName":"UML DEFAULT CD","context":"caCORE","contextVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5E53F3B-47A4-52D1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-04-29","modifiedBy":"DWARZEL","dateModified":"2021-04-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"20416CA9-03C2-138C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-20","endDate":null,"createdBy":"UMLLOADER_CGOM","dateCreated":"2006-10-20","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2529046","version":"1","preferredName":"Loss Result Type","preferredDefinition":"indicates the 3 level result, it is only assessable if benign tissue present_Type; a subdivision of a particular kind of thing.","longName":"2529046v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"no_loss","valueDescription":"None Loss","ValueMeaning":{"publicId":"2581862","version":"1","preferredName":"None Loss","longName":"2581862","preferredDefinition":"No person or thing, nobody, not any.:A gradual decline in amount or activity.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0CD3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-13","endDate":null,"createdBy":"CURTIST","dateCreated":"2006-11-13","modifiedBy":"CURTIST","dateModified":"2006-11-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"22292193-8EE9-57EE-E044-0003BA3F9857","beginDate":"2006-11-13","endDate":null,"createdBy":"CURTIST","dateCreated":"2006-11-13","modifiedBy":"CURTIST","dateModified":"2006-11-13","deletedIndicator":"No"},{"value":"partial_loss","valueDescription":"Partial Loss","ValueMeaning":{"publicId":"2581863","version":"1","preferredName":"Partial Loss","longName":"2581863","preferredDefinition":"Being or affecting only a part of something.:A gradual decline in amount or activity.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0CD4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-13","endDate":null,"createdBy":"CURTIST","dateCreated":"2006-11-13","modifiedBy":"CURTIST","dateModified":"2006-11-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"22292193-8EF5-57EE-E044-0003BA3F9857","beginDate":"2006-11-13","endDate":null,"createdBy":"CURTIST","dateCreated":"2006-11-13","modifiedBy":"CURTIST","dateModified":"2006-11-13","deletedIndicator":"No"},{"value":"total_loss","valueDescription":"Total Loss","ValueMeaning":{"publicId":"2581864","version":"1","preferredName":"Total Loss","longName":"2581864","preferredDefinition":"Pertaining to an entirety or whole, also constituting the full quantity or extent; complete; derived by addition.:A gradual decline in amount or activity.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0CD5-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-13","endDate":null,"createdBy":"CURTIST","dateCreated":"2006-11-13","modifiedBy":"CURTIST","dateModified":"2006-11-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"22292193-8F01-57EE-E044-0003BA3F9857","beginDate":"2006-11-13","endDate":null,"createdBy":"CURTIST","dateCreated":"2006-11-13","modifiedBy":"CURTIST","dateModified":"2006-11-13","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"20417B52-C36E-1F37-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-20","endDate":null,"createdBy":"UMLLOADER_CGOM","dateCreated":"2006-10-20","modifiedBy":"SBR","dateModified":"2008-12-08","changeDescription":"Representation term 'Type' added per request of loading team to suport SIW requirements on 7/31/2008","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2528519","version":"2","longName":"caIntegrator","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812323","version":"1","longName":"gov.nih.nci.caintegrator.domain.finding.protein.ihc","context":"NCIP"}]},{"publicId":"2707890","version":"2.1","longName":"caIntegrator 2.1","context":"NCIP","ClassificationSchemeItems":[{"publicId":"10000564","version":"1","longName":"gov.nih.nci.caintegrator.domain.finding.protein.ihc","context":"NCIP"}]}],"AlternateNames":[{"name":"gov.nih.nci.caintegrator.domain.finding.protein.ihc.LossOfExpressionIHCFinding.lossResult","type":"UML Qualified Attr","context":"NCIP"},{"name":"LossOfExpressionIHCFinding:lossResult","type":"UML Class:UML Attr","context":"NCIP"}],"ReferenceDocuments":[{"name":"Data Element Loss Gene Expression Immunohistochemistry Staining Method Finding Loss Outcome LossResult does not have Preferred Question Text","type":"Preferred Question Text","description":"Data Element Loss Gene Expression Immunohistochemistry Staining Method Finding Loss Outcome LossResult does not have Preferred Question Text","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"20408E97-B1E7-3107-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-20","endDate":null,"createdBy":"UMLLOADER_CGOM","dateCreated":"2006-10-20","modifiedBy":"CURTIST","dateModified":"2008-04-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}